Connection

Marco Metra to Immunosuppressive Agents

Back to Details
This is a "connection" page, showing publications Marco Metra has written about Immunosuppressive Agents.
Marco Metra
Connection Strength
0.261
Immunosuppressive Agents
  1. The systemic sclerosis patient in the COVID-19 era: the challenging crossroad between immunosuppression, differential diagnosis and long-term psychological distress. Clin Rheumatol. 2020 Jul; 39(7):2043-2047.
    View in: PubMed
    Score: 0.056
  2. Systemic sclerosis and the COVID-19 pandemic: World Scleroderma Foundation preliminary advice for patient management. Ann Rheum Dis. 2020 06; 79(6):724-726.
    View in: PubMed
    Score: 0.056
  3. COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs Turk J Med Sci. 2020 04 21; 50(SI-1):620-632.
    View in: PubMed
    Score: 0.056
  4. Systemic sclerosis associated interstitial lung disease - individualized immunosuppressive therapy and course of lung function: results of the EUSTAR group. Arthritis Res Ther. 2018 01 30; 20(1):17.
    View in: PubMed
    Score: 0.048
  5. Treatment outcome in early diffuse cutaneous systemic sclerosis: the European Scleroderma Observational Study (ESOS). Ann Rheum Dis. 2017 Jul; 76(7):1207-1218.
    View in: PubMed
    Score: 0.045
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.